Nkarta (NKTX) Amortizatization of Intangibles (2020 - 2026)

Nkarta's (NKTX) quarterly Amortizatization of Intangibles came in at $753000.0 in Q1 2026, down 51.88% year-on-year from $1.6 million in Q1 2025, and down 11.93% quarter-over-quarter from $855000.0 in Q4 2025.

Nkarta (NKTX) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Nkarta's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $753000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 51.88% year-over-year to $753000.0 in Q1 2026; TTM through Mar 2026 was $3.8 million, a 45.46% decrease from a year earlier, with the FY2025 full-year figure at $4.6 million, down 33.74% from the prior year.
  • Amortizatization of Intangibles declined to $753000.0 in Q1 2026 per NKTX's latest filing, from $855000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.4 million in Q3 2023 and bottomed at -$727000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $1.6 million (2025), against an average of $1.3 million.
  • Across the five-year window, Amortizatization of Intangibles jumped 689.56% in 2023 and tumbled 55.79% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $1.6 million in 2022, then advanced by 28.08% to $2.0 million in 2023, then dropped by 4.49% to $1.9 million in 2024, then sank by 55.79% to $855000.0 in 2025, then retreated by 11.93% to $753000.0 in 2026.
  • Per Business Quant, the three latest NKTX Amortizatization of Intangibles figures stand at $753000.0 (Q1 2026), $855000.0 (Q4 2025), and $953000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Nkarta 168.94 Mn 168.94 Mn - 753,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 753,000.00
Mar 31, 2026 753,000.00
Dec 31, 2025 855,000.00
Dec 31, 2025 855,000.00
Sep 30, 2025 953,000.00
Sep 30, 2025 953,000.00
Jun 30, 2025 1.21 Mn
Jun 30, 2025 1.21 Mn
Mar 31, 2025 1.57 Mn
Mar 31, 2025 1.57 Mn
Dec 31, 2024 1.93 Mn
Dec 31, 2024 1.93 Mn
Sep 30, 2024 1.96 Mn
Sep 30, 2024 1.96 Mn
Jun 30, 2024 1.45 Mn
Jun 30, 2024 1.45 Mn
Mar 31, 2024 1.57 Mn
Mar 31, 2024 1.57 Mn
Dec 31, 2023 2.03 Mn
Dec 31, 2023 2.03 Mn